Phase 1 Trial of SBS-147 in Healthy Adults
Phase 1
80
about 1.1 years
18–55
1 site in CA
About this study
This trial is testing the safety and how people's bodies react to SBS-147. Participants will receive either SBS-147 or a placebo, which looks like SBS-147 but has no medicine. The study involves both a single dose and multiple doses of SBS-147 over 409 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take SBS-147
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Number of participants with treatment-related adverse events as assessed by CTCAE v5.0, Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 at ascending doses
Secondary: Plasma pharmacokinetics of SBS-1000 and SBS-147 following multiple ascending doses